MacroGenics Inc.

(MGNX) Trade

By |

Profile

Macrogenics Inc is a clinical-stage biopharmaceutical company. It focusses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases.

Contact Information

Website: www.macrogenics.com
Main Phone: +1 301 251-5172
Address: 9704 Medical Center Drive
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NGS
CEO: Scott Koenig
Employees: 330
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 22.13 $ 0.33 (1.51%)
Last Price 22.13 Change $ 0.33 Change % 1.51 Tick N/A
Bid 22.13 Bid Size 100.00 Ask 22.18 Ask Size 100.00
Open 21.81 High 22.73 Low 21.64 Prev Close 21.80
Last Trade Volume 160,912 52 Wk Hi 32.74 52 Wk Low 14.36
Market Cap 933.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 42,202,078.00 EPS (TTM) -0.80 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 29
Number of Buys 0 18
Number of Sells 0 11
Net Activity 0 55710
Last 10 Buys Shares
Paulo F. Costa 1,000
Kenneth Galbraith 1,000
Last 10 Sell Shares
Eric Risser 1,000
James Karrels 1,000
Eric Risser 1,000
Eric Risser 1,000
Lynn Cilinski 1,000
Eric Risser 1,000
Jon Wigginton 1,000
Jon Wigginton 1,000
Jon Wigginton 1,000
Jon Wigginton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 44 44 44 44
Low Target Price Estimate 21 21 21 21
Mean Target Price Estimate 31.11 31.11 30.88 31.11
Standard Deviation 7.18 7.18 7.64 7.18
Date of Most Recent Estimate 05/31/18 05/31/18 05/16/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 6 6 6
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.56 1.56 1.56